Kelly R.

Kelly R. has a diverse work experience in the pharmaceutical and clinical research industry. Kelly has held various leadership roles in different companies, starting with their current position as a Director, Clinical Project Lead at Genmab since 2023. Prior to this, they worked at The Janssen Pharmaceutical Companies of Johnson & Johnson as a Director, Global Program Lead Oncology from 2020 to 2023, and as an Associate Director, ED Onc GTL from 2018 to 2020.

Before joining Janssen, Kelly worked at Bristol-Myers Squibb, where they held positions such as Director, Vendor Relationship Lead from 2017 to 2018, Associate Director, CS&O Line Management from 2016 to 2017, and Senior Clinical Scientist from 2015 to 2016.

Kelly also gained experience at Celgene as a Senior Study Manager from 2014 to 2015, and at Novo Nordisk A/S as a Line Manager, Site Management from 2013 to 2014 and as an International Clinical Trial Manager from 2012 to 2013.

Kelly'scareer began at BMS in 2003, where they served as a Senior Protocol Manager from 2003 to 2012. Prior to that, they worked as a Data Manager at Beardsworth from 2002 to 2003 and as a Lead Clinical Data Manager at Covance from 2001 to 2002. Overall, their extensive work experience showcases their expertise in clinical project management, oncology, vendor relationship management, and site management.

Kelly R. completed their Bachelor of Science degree in Biology from Saint Joseph's University, attending from 1992 to 1996. Kelly later pursued their Master of Business Administration (MBA) from LaSalle University, studying from 2011 to 2020. The field of study for their MBA is not provided.